Literature DB >> 18181715

US Food and Drug Administration regulations governing label claims for food products, including probiotics.

Leila G Saldanha1.   

Abstract

The US Congress has granted the Food and Drug Administration the authority to permit manufacturers to use claims in food labels that fit into the following broad categories: health claims, structure/function claims, nutrient content claims, and dietary guidance messages. This article outlines the scope and evolution of these claims and how they are used in the marketing of probiotics. Probiotics are live microorganisms (in most cases, bacteria) that are similar to beneficial microorganisms found in the human gut.

Entities:  

Mesh:

Year:  2008        PMID: 18181715     DOI: 10.1086/523328

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Probiotics in the next-generation sequencing era.

Authors:  Jotham Suez; Niv Zmora; Eran Elinav
Journal:  Gut Microbes       Date:  2019-04-05

Review 2.  Establishing and evaluating health claims for probiotics.

Authors:  Sharon M Donovan; Barbara Schneeman; Glenn R Gibson; Mary Ellen Sanders
Journal:  Adv Nutr       Date:  2012-09-01       Impact factor: 8.701

3.  Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.

Authors:  S A Cohen; M C Woodfield; N Boyle; Z Stednick; M Boeckh; S A Pergam
Journal:  Transpl Infect Dis       Date:  2016-09-21       Impact factor: 2.228

4.  Labeling quality and molecular characterization studies of products containing Lactobacillus spp. strains.

Authors:  Giovanna Blandino; Davide Fazio; Giulio Petronio Petronio; Rosanna Inturri; Gianna Tempera; Pio Maria Furneri
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-14       Impact factor: 3.219

5.  ICMR-DBT guidelines for evaluation of probiotics in food.

Authors: 
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

6.  Mismatch between Probiotic Benefits in Trials versus Food Products.

Authors:  Mary J Scourboutakos; Beatriz Franco-Arellano; Sarah A Murphy; Sheida Norsen; Elena M Comelli; Mary R L'Abbé
Journal:  Nutrients       Date:  2017-04-19       Impact factor: 5.717

7.  Regulatory oversight and safety of probiotic use.

Authors:  Veena Venugopalan; Kimberly A Shriner; Annie Wong-Beringer
Journal:  Emerg Infect Dis       Date:  2010-11       Impact factor: 6.883

8.  Probiotics in the arabian gulf region.

Authors:  Abiola C Senok
Journal:  Food Nutr Res       Date:  2009-03-04       Impact factor: 3.894

9.  Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial.

Authors:  Stephen B Freedman; Sarah Williamson-Urquhart; Suzanne Schuh; Philip M Sherman; Ken J Farion; Serge Gouin; Andrew R Willan; Ron Goeree; David W Johnson; Karen Black; David Schnadower; Marc H Gorelick
Journal:  Trials       Date:  2014-05-14       Impact factor: 2.279

10.  Identification of New Potential Biotherapeutics from Human Gut Microbiota-Derived Bacteria.

Authors:  Bernardo Cuffaro; Aka L W Assohoun; Denise Boutillier; Véronique Peucelle; Jérémy Desramaut; Samira Boudebbouze; Mikael Croyal; Anne-Judith Waligora-Dupriet; Moez Rhimi; Corinne Grangette; Emmanuelle Maguin
Journal:  Microorganisms       Date:  2021-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.